House of Lords in favour of Lundbeck's enantiomer patent
This article was originally published in Scrip
Executive Summary
The UK House of Lords has ruled in favour of a patent on Lundbeck's single-isomer, antidepressant, escitalopram (Cipralex/Lexapro), even though the only truly inventive step was the process of making it.